Barbara J. Wilimczyk-Macri

FDA investigator

Appears on 5 documents from 2012 to 2016, mostly at sites in New Jersey. Most often cites design and construction features (21 CFR 211.42).

5
Documents on file
11.0
Observations per 483
2012
First seen
2016
Most recent

What they cite most

From 55 observations

Activity by year

2012: 1, 2013: 1, 2015: 2, 2016: 1

Where

New Jersey 5

Is Barbara J. Wilimczyk-Macri coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 Akorn Operating Company LLC (dba Akorn)Apr 4, 2016 · Somerset, New Jersey
483 PharMEDium Services, LLCJul 13, 2015 · Edison, New Jersey
483 Liberty Drug & SurgicalMay 22, 2015 · Chatham, New Jersey
483 MedPREP Consulting Inc.Apr 3, 2013 · Tinton Falls, New Jersey
483 Integra LifeSciences CorporationJul 30, 2012 · Plainsboro, New Jersey

About this profile

What does Barbara J. Wilimczyk-Macri inspect?

Barbara J. Wilimczyk-Macri appears on 5 documents on file covering 5 sites, mostly in New Jersey.

What do they cite most often?

21 CFR 211.42 (design and construction features), followed by 21 CFR 211.113 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Barbara J. Wilimczyk-Macri is dated Apr 4, 2016.